Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.27106234 |
2 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.02267589 |
3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.82702414 |
4 | positive regulation by symbiont of host defense response (GO:0052509) | 4.72583306 |
5 | modulation by symbiont of host defense response (GO:0052031) | 4.72583306 |
6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.72583306 |
7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.72583306 |
8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.72583306 |
9 | modulation by symbiont of host immune response (GO:0052553) | 4.72583306 |
10 | B cell receptor signaling pathway (GO:0050853) | 4.51249351 |
11 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.50833610 |
12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.35552960 |
13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.27738977 |
14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.27738977 |
15 | detection of other organism (GO:0098543) | 4.19493813 |
16 | detection of bacterium (GO:0016045) | 4.15740042 |
17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.97470810 |
18 | negative regulation of cell killing (GO:0031342) | 3.97470810 |
19 | negative regulation of phagocytosis (GO:0050765) | 3.97237412 |
20 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.92105212 |
21 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.90404907 |
22 | * positive regulation of B cell differentiation (GO:0045579) | 3.89305336 |
23 | macrophage activation involved in immune response (GO:0002281) | 3.85261087 |
24 | positive T cell selection (GO:0043368) | 3.80417454 |
25 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.76951279 |
26 | negative regulation of T cell mediated immunity (GO:0002710) | 3.74041766 |
27 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.73926787 |
28 | regulation of gamma-delta T cell activation (GO:0046643) | 3.70464048 |
29 | T cell selection (GO:0045058) | 3.68784433 |
30 | cellular extravasation (GO:0045123) | 3.61975527 |
31 | cellular response to interleukin-15 (GO:0071350) | 3.61931304 |
32 | * regulation of B cell differentiation (GO:0045577) | 3.54833415 |
33 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.54089480 |
34 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.52779982 |
35 | tolerance induction (GO:0002507) | 3.44937036 |
36 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.43707494 |
37 | detection of external biotic stimulus (GO:0098581) | 3.43396745 |
38 | positive regulation of interferon-alpha production (GO:0032727) | 3.42720044 |
39 | neutrophil activation involved in immune response (GO:0002283) | 3.42622429 |
40 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.37687195 |
41 | regulation of interferon-alpha production (GO:0032647) | 3.31090870 |
42 | microglial cell activation (GO:0001774) | 3.29598213 |
43 | positive thymic T cell selection (GO:0045059) | 3.28592786 |
44 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.27601816 |
45 | type I interferon signaling pathway (GO:0060337) | 3.25454726 |
46 | cellular response to type I interferon (GO:0071357) | 3.25454726 |
47 | response to type I interferon (GO:0034340) | 3.24225567 |
48 | respiratory burst (GO:0045730) | 3.18381737 |
49 | myeloid cell activation involved in immune response (GO:0002275) | 3.16274032 |
50 | positive regulation of antigen processing and presentation (GO:0002579) | 3.15569156 |
51 | regulation of leukocyte degranulation (GO:0043300) | 3.14892395 |
52 | leukocyte aggregation (GO:0070486) | 3.13497750 |
53 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.13341304 |
54 | regulation of tolerance induction (GO:0002643) | 3.09689820 |
55 | pinocytosis (GO:0006907) | 3.08890840 |
56 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.07140209 |
57 | * B cell mediated immunity (GO:0019724) | 3.06388655 |
58 | neutrophil activation (GO:0042119) | 3.04516978 |
59 | detection of biotic stimulus (GO:0009595) | 3.03888436 |
60 | response to muramyl dipeptide (GO:0032495) | 3.03453027 |
61 | B cell homeostasis (GO:0001782) | 3.02984516 |
62 | regulation of T cell tolerance induction (GO:0002664) | 3.02585178 |
63 | mature B cell differentiation (GO:0002335) | 3.00536268 |
64 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.99345499 |
65 | Peyers patch development (GO:0048541) | 2.99171713 |
66 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.99171713 |
67 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.99119146 |
68 | mast cell activation (GO:0045576) | 2.98903756 |
69 | negative regulation of interleukin-12 production (GO:0032695) | 2.97656083 |
70 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.95634758 |
71 | leukocyte degranulation (GO:0043299) | 2.95594273 |
72 | detection of molecule of bacterial origin (GO:0032490) | 2.95352013 |
73 | activated T cell proliferation (GO:0050798) | 2.94298233 |
74 | * immunoglobulin mediated immune response (GO:0016064) | 2.93896829 |
75 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.93099984 |
76 | response to host immune response (GO:0052572) | 2.93099984 |
77 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.92706796 |
78 | myeloid dendritic cell activation (GO:0001773) | 2.91995383 |
79 | positive regulation of mast cell degranulation (GO:0043306) | 2.90907443 |
80 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.90907443 |
81 | response to peptidoglycan (GO:0032494) | 2.89302134 |
82 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.88881191 |
83 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.88881191 |
84 | lymphocyte homeostasis (GO:0002260) | 2.88279613 |
85 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.87942740 |
86 | T cell migration (GO:0072678) | 2.87781726 |
87 | response to host (GO:0075136) | 2.83694583 |
88 | response to host defenses (GO:0052200) | 2.83694583 |
89 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.83694583 |
90 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.83612414 |
91 | regulation of mast cell degranulation (GO:0043304) | 2.83281550 |
92 | defense response to protozoan (GO:0042832) | 2.83196820 |
93 | natural killer cell differentiation (GO:0001779) | 2.82769186 |
94 | granulocyte activation (GO:0036230) | 2.81556284 |
95 | T cell homeostasis (GO:0043029) | 2.81152518 |
96 | negative thymic T cell selection (GO:0045060) | 2.80777965 |
97 | cellular response to zinc ion (GO:0071294) | 2.78145365 |
98 | response to protozoan (GO:0001562) | 2.77333492 |
99 | positive regulation of chemokine secretion (GO:0090197) | 2.76917680 |
100 | macrophage activation (GO:0042116) | 2.70974977 |
101 | megakaryocyte development (GO:0035855) | 2.70313279 |
102 | germinal center formation (GO:0002467) | 2.69370067 |
103 | negative T cell selection (GO:0043383) | 2.68135093 |
104 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.65239330 |
105 | positive regulation of interferon-beta production (GO:0032728) | 2.65150019 |
106 | regulation of mast cell activation (GO:0033003) | 2.63876734 |
107 | regulation of antigen processing and presentation (GO:0002577) | 2.60599913 |
108 | mature B cell differentiation involved in immune response (GO:0002313) | 2.60175799 |
109 | hepatocyte apoptotic process (GO:0097284) | 2.60097064 |
110 | regulation of B cell apoptotic process (GO:0002902) | 2.58277742 |
111 | B cell proliferation (GO:0042100) | 2.58237554 |
112 | myeloid leukocyte activation (GO:0002274) | 2.57300746 |
113 | * antigen receptor-mediated signaling pathway (GO:0050851) | 2.55821939 |
114 | mast cell activation involved in immune response (GO:0002279) | 2.55301150 |
115 | mast cell degranulation (GO:0043303) | 2.55301150 |
116 | response to interleukin-15 (GO:0070672) | 2.54528225 |
117 | myeloid dendritic cell differentiation (GO:0043011) | 2.53323260 |
118 | NIK/NF-kappaB signaling (GO:0038061) | 2.51033335 |
119 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.50794144 |
120 | leukocyte homeostasis (GO:0001776) | 2.50234630 |
121 | mannose metabolic process (GO:0006013) | 2.50228674 |
122 | interferon-gamma production (GO:0032609) | 2.50136105 |
123 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.49869570 |
124 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.48559711 |
125 | leukocyte cell-cell adhesion (GO:0007159) | 2.47417243 |
126 | positive regulation of granulocyte differentiation (GO:0030854) | 2.47259780 |
127 | positive regulation of mast cell activation (GO:0033005) | 2.46841885 |
128 | thymic T cell selection (GO:0045061) | 2.43892769 |
129 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.41768415 |
130 | adaptation of signaling pathway (GO:0023058) | 2.40638061 |
131 | germ cell migration (GO:0008354) | 2.40624527 |
132 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.40569785 |
133 | dendritic cell differentiation (GO:0097028) | 2.40279718 |
134 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.38067621 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.28759007 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.89214567 |
3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.72463404 |
4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.51299058 |
5 | MYC_22102868_ChIP-Seq_BL_Human | 3.28322007 |
6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.26053362 |
7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.19127414 |
8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.12398582 |
9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.05706347 |
10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.04953322 |
11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.02818909 |
12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.92845400 |
13 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.86695889 |
14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.86243544 |
15 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.82435458 |
16 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.77281506 |
17 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.51067309 |
18 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.45511164 |
19 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.38952163 |
20 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.31449669 |
21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.29402278 |
22 | MYB_26560356_Chip-Seq_TH2_Human | 2.18633036 |
23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.13840958 |
24 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12847104 |
25 | MAF_26560356_Chip-Seq_TH1_Human | 2.12123401 |
26 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.07828189 |
27 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.07583432 |
28 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.07279452 |
29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.05424486 |
30 | MYB_26560356_Chip-Seq_TH1_Human | 2.02798644 |
31 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.00884805 |
32 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.00246731 |
33 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.99366960 |
34 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.98491865 |
35 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.95161921 |
36 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.90935060 |
37 | UTX_26944678_Chip-Seq_JUKART_Human | 1.89399536 |
38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.88877000 |
39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.87437114 |
40 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75816805 |
41 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74876920 |
42 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.67903955 |
43 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.66878506 |
44 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63956593 |
45 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.62618713 |
46 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.56855535 |
47 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.56608207 |
48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53687133 |
49 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.50918456 |
50 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.44161757 |
51 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.43035759 |
52 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.41969616 |
53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.40331252 |
54 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.35610838 |
55 | MAF_26560356_Chip-Seq_TH2_Human | 1.35087839 |
56 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34810388 |
57 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.34513740 |
58 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.33641839 |
59 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.32324203 |
60 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.32312043 |
61 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.31433491 |
62 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.30041405 |
63 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30037690 |
64 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.28385358 |
65 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.27126958 |
66 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.25709187 |
67 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.24109048 |
68 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20479382 |
69 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20209825 |
70 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19934608 |
71 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.18718097 |
72 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.18660779 |
73 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.18095284 |
74 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.17699442 |
75 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17010290 |
76 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16254227 |
77 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.15236136 |
78 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.15163795 |
79 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14284789 |
80 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.13620121 |
81 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.12602023 |
82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12468421 |
83 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.10506849 |
84 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.09990105 |
85 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09609291 |
86 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.06336588 |
87 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04981823 |
88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04364501 |
89 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.03536769 |
90 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02441653 |
91 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01394825 |
92 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01313311 |
93 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.00852257 |
94 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.99939288 |
95 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 0.99601547 |
96 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.98470738 |
97 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.96942693 |
98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93402076 |
99 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.93108525 |
100 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.93052964 |
101 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92776229 |
102 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.89564132 |
103 | GATA3_26560356_Chip-Seq_TH2_Human | 0.89412603 |
104 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89236430 |
105 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.88455796 |
106 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.88124099 |
107 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.85046220 |
108 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84457860 |
109 | * SPI1_20517297_ChIP-Seq_HL60_Human | 0.84416511 |
110 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83809834 |
111 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.82325842 |
112 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80163000 |
113 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.78672549 |
114 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.76923606 |
115 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.76488298 |
116 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.74865900 |
117 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74651836 |
118 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74001155 |
119 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73896780 |
120 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73641367 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 4.18233658 |
2 | MP0002396_abnormal_hematopoietic_system | 3.09333386 |
3 | * MP0001800_abnormal_humoral_immune | 3.01024972 |
4 | MP0003303_peritoneal_inflammation | 2.93194216 |
5 | MP0000685_abnormal_immune_system | 2.73932004 |
6 | * MP0002452_abnormal_antigen_presenting | 2.73906429 |
7 | * MP0005671_abnormal_response_to | 2.71868003 |
8 | MP0003436_decreased_susceptibility_to | 2.66820380 |
9 | MP0005387_immune_system_phenotype | 2.66186704 |
10 | MP0001790_abnormal_immune_system | 2.66186704 |
11 | MP0005000_abnormal_immune_tolerance | 2.59919169 |
12 | * MP0002723_abnormal_immune_serum | 2.49818308 |
13 | * MP0002420_abnormal_adaptive_immunity | 2.47861298 |
14 | * MP0001819_abnormal_immune_cell | 2.46496719 |
15 | * MP0002419_abnormal_innate_immunity | 2.43042354 |
16 | * MP0002398_abnormal_bone_marrow | 2.38331015 |
17 | MP0006082_CNS_inflammation | 2.36309508 |
18 | * MP0005025_abnormal_response_to | 2.25090595 |
19 | * MP0005464_abnormal_platelet_physiology | 2.24330294 |
20 | MP0003172_abnormal_lysosome_physiology | 2.20059053 |
21 | MP0005058_abnormal_lysosome_morphology | 2.18119110 |
22 | MP0009785_altered_susceptibility_to | 2.17949227 |
23 | MP0003763_abnormal_thymus_physiology | 2.14736338 |
24 | * MP0000689_abnormal_spleen_morphology | 2.13838817 |
25 | * MP0000716_abnormal_immune_system | 2.12880972 |
26 | MP0009278_abnormal_bone_marrow | 2.06695794 |
27 | MP0004808_abnormal_hematopoietic_stem | 2.04961986 |
28 | MP0003300_gastrointestinal_ulcer | 2.04947710 |
29 | MP0002148_abnormal_hypersensitivity_rea | 2.03783203 |
30 | MP0002405_respiratory_system_inflammati | 2.01931609 |
31 | * MP0002722_abnormal_immune_system | 2.00434711 |
32 | MP0000465_gastrointestinal_hemorrhage | 1.98894199 |
33 | MP0002166_altered_tumor_susceptibility | 1.93305923 |
34 | MP0008057_abnormal_DNA_replication | 1.92418179 |
35 | MP0001545_abnormal_hematopoietic_system | 1.92027545 |
36 | MP0005397_hematopoietic_system_phenotyp | 1.92027545 |
37 | * MP0002429_abnormal_blood_cell | 1.85113304 |
38 | MP0001873_stomach_inflammation | 1.84940500 |
39 | MP0003191_abnormal_cellular_cholesterol | 1.80802455 |
40 | MP0009333_abnormal_splenocyte_physiolog | 1.78774512 |
41 | MP0001853_heart_inflammation | 1.75326678 |
42 | MP0010155_abnormal_intestine_physiology | 1.64352733 |
43 | MP0010307_abnormal_tumor_latency | 1.64187920 |
44 | MP0010094_abnormal_chromosome_stability | 1.62037510 |
45 | * MP0000703_abnormal_thymus_morphology | 1.61109060 |
46 | MP0005174_abnormal_tail_pigmentation | 1.60149747 |
47 | MP0001845_abnormal_inflammatory_respons | 1.59174061 |
48 | MP0000569_abnormal_digit_pigmentation | 1.55407350 |
49 | MP0004510_myositis | 1.54298020 |
50 | MP0004947_skin_inflammation | 1.54136138 |
51 | MP0000490_abnormal_crypts_of | 1.53505215 |
52 | MP0002006_tumorigenesis | 1.48662206 |
53 | MP0003077_abnormal_cell_cycle | 1.43281116 |
54 | MP0003693_abnormal_embryo_hatching | 1.41323295 |
55 | MP0003111_abnormal_nucleus_morphology | 1.39848033 |
56 | MP0005451_abnormal_body_composition | 1.39357389 |
57 | MP0003724_increased_susceptibility_to | 1.37971491 |
58 | MP0010352_gastrointestinal_tract_polyps | 1.37149925 |
59 | MP0001533_abnormal_skeleton_physiology | 1.32852009 |
60 | MP0008260_abnormal_autophagy | 1.32027908 |
61 | MP0005310_abnormal_salivary_gland | 1.31350933 |
62 | MP0003183_abnormal_peptide_metabolism | 1.30870264 |
63 | MP0004381_abnormal_hair_follicle | 1.30383554 |
64 | MP0008007_abnormal_cellular_replicative | 1.27517030 |
65 | MP0003866_abnormal_defecation | 1.21538783 |
66 | MP0009840_abnormal_foam_cell | 1.18091524 |
67 | * MP0008469_abnormal_protein_level | 1.17740544 |
68 | MP0000858_altered_metastatic_potential | 1.15711016 |
69 | MP0003448_altered_tumor_morphology | 1.14292832 |
70 | MP0003566_abnormal_cell_adhesion | 1.13568914 |
71 | MP0002019_abnormal_tumor_incidence | 1.12921225 |
72 | MP0005075_abnormal_melanosome_morpholog | 1.12681414 |
73 | MP0002009_preneoplasia | 1.11617605 |
74 | MP0001986_abnormal_taste_sensitivity | 1.10677418 |
75 | MP0008058_abnormal_DNA_repair | 1.10414842 |
76 | MP0005076_abnormal_cell_differentiation | 1.10358003 |
77 | MP0002138_abnormal_hepatobiliary_system | 1.10012305 |
78 | MP0000015_abnormal_ear_pigmentation | 1.06311701 |
79 | MP0001851_eye_inflammation | 1.05266017 |
80 | MP0002933_joint_inflammation | 1.04156087 |
81 | MP0000343_altered_response_to | 1.00567019 |
82 | MP0004883_abnormal_blood_vessel | 0.90774352 |
83 | MP0003075_altered_response_to | 0.88163588 |
84 | MP0004957_abnormal_blastocyst_morpholog | 0.86670438 |
85 | MP0003828_pulmonary_edema | 0.86102318 |
86 | MP0000313_abnormal_cell_death | 0.85824890 |
87 | MP0005023_abnormal_wound_healing | 0.81652941 |
88 | MP0000350_abnormal_cell_proliferation | 0.81484664 |
89 | MP0002095_abnormal_skin_pigmentation | 0.79697269 |
90 | MP0000371_diluted_coat_color | 0.79371945 |
91 | MP0001915_intracranial_hemorrhage | 0.76788568 |
92 | MP0002998_abnormal_bone_remodeling | 0.75146680 |
93 | MP0005166_decreased_susceptibility_to | 0.74938012 |
94 | MP0002928_abnormal_bile_duct | 0.71970046 |
95 | MP0003690_abnormal_glial_cell | 0.71595389 |
96 | MP0002277_abnormal_respiratory_mucosa | 0.70173106 |
97 | MP0003656_abnormal_erythrocyte_physiolo | 0.69635320 |
98 | MP0009763_increased_sensitivity_to | 0.68761611 |
99 | MP0000604_amyloidosis | 0.68477611 |
100 | MP0002132_abnormal_respiratory_system | 0.67019992 |
101 | MP0000249_abnormal_blood_vessel | 0.66119272 |
102 | MP0009765_abnormal_xenobiotic_induced | 0.65601833 |
103 | MP0008873_increased_physiological_sensi | 0.65419214 |
104 | MP0009764_decreased_sensitivity_to | 0.61617907 |
105 | MP0003453_abnormal_keratinocyte_physiol | 0.60374663 |
106 | MP0005164_abnormal_response_to | 0.60260986 |
107 | MP0005390_skeleton_phenotype | 0.60074517 |
108 | MP0005621_abnormal_cell_physiology | 0.59187018 |
109 | MP0003045_fibrosis | 0.58094670 |
110 | MP0008004_abnormal_stomach_pH | 0.57951920 |
111 | MP0003795_abnormal_bone_structure | 0.56854109 |
112 | MP0001663_abnormal_digestive_system | 0.55893026 |
113 | MP0008961_abnormal_basal_metabolism | 0.55288551 |
114 | MP0000477_abnormal_intestine_morphology | 0.55287508 |
115 | MP0006054_spinal_hemorrhage | 0.54098259 |
116 | MP0000598_abnormal_liver_morphology | 0.52649883 |
117 | MP0008874_decreased_physiological_sensi | 0.50942131 |
118 | MP0003878_abnormal_ear_physiology | 0.50880222 |
119 | MP0005377_hearing/vestibular/ear_phenot | 0.50880222 |
120 | MP0002693_abnormal_pancreas_physiology | 0.50189304 |
121 | MP0000609_abnormal_liver_physiology | 0.47655810 |
122 | MP0009115_abnormal_fat_cell | 0.46664893 |
123 | MP0004130_abnormal_muscle_cell | 0.45660425 |
124 | MP0003091_abnormal_cell_migration | 0.44220998 |
125 | MP0005381_digestive/alimentary_phenotyp | 0.41403365 |
126 | MP0005319_abnormal_enzyme/_coenzyme | 0.39449209 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.15522149 |
2 | Recurrent bacterial skin infections (HP:0005406) | 4.67068793 |
3 | Cellulitis (HP:0100658) | 4.29652403 |
4 | Eczematoid dermatitis (HP:0000976) | 4.22139313 |
5 | IgM deficiency (HP:0002850) | 4.18606180 |
6 | Agammaglobulinemia (HP:0004432) | 4.10094196 |
7 | Recurrent viral infections (HP:0004429) | 4.01991800 |
8 | Recurrent fungal infections (HP:0002841) | 3.84778230 |
9 | Colitis (HP:0002583) | 3.77239707 |
10 | Systemic lupus erythematosus (HP:0002725) | 3.65528152 |
11 | Inflammation of the large intestine (HP:0002037) | 3.53562402 |
12 | Meningitis (HP:0001287) | 3.52765963 |
13 | Gastrointestinal infarctions (HP:0005244) | 3.49985698 |
14 | Myositis (HP:0100614) | 3.49718643 |
15 | Gastrointestinal inflammation (HP:0004386) | 3.47031913 |
16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.43502077 |
17 | Panhypogammaglobulinemia (HP:0003139) | 3.36363152 |
18 | Chronic otitis media (HP:0000389) | 3.21043142 |
19 | Recurrent skin infections (HP:0001581) | 3.20246206 |
20 | Recurrent bronchitis (HP:0002837) | 3.17923982 |
21 | Thyroiditis (HP:0100646) | 3.13172837 |
22 | Agnosia (HP:0010524) | 3.10769700 |
23 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.08790238 |
24 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.06586221 |
25 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.06586221 |
26 | Abnormality of glycolipid metabolism (HP:0010969) | 3.06586221 |
27 | Increased IgM level (HP:0003496) | 3.04861420 |
28 | Petechiae (HP:0000967) | 3.00850749 |
29 | Increased cerebral lipofuscin (HP:0011813) | 2.99095267 |
30 | Urticaria (HP:0001025) | 2.98718990 |
31 | Osteomyelitis (HP:0002754) | 2.96947202 |
32 | Abnormality of the fingertips (HP:0001211) | 2.96587461 |
33 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.95469964 |
34 | Recurrent cutaneous fungal infections (HP:0011370) | 2.95469964 |
35 | Chronic obstructive pulmonary disease (HP:0006510) | 2.95022328 |
36 | Obstructive lung disease (HP:0006536) | 2.95022328 |
37 | Prolonged bleeding time (HP:0003010) | 2.93538451 |
38 | Mediastinal lymphadenopathy (HP:0100721) | 2.92512167 |
39 | Keratoconjunctivitis sicca (HP:0001097) | 2.92467305 |
40 | Thrombocytosis (HP:0001894) | 2.92448106 |
41 | Spontaneous hematomas (HP:0007420) | 2.90710296 |
42 | Verrucae (HP:0200043) | 2.87371024 |
43 | Papilloma (HP:0012740) | 2.87371024 |
44 | Autoimmune hemolytic anemia (HP:0001890) | 2.86314232 |
45 | Abnormality of macrophages (HP:0004311) | 2.83925206 |
46 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.83231955 |
47 | Hemoptysis (HP:0002105) | 2.78262178 |
48 | Glomerulonephritis (HP:0000099) | 2.77975338 |
49 | Vasculitis (HP:0002633) | 2.76257713 |
50 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.74546141 |
51 | Keratoconjunctivitis (HP:0001096) | 2.72901065 |
52 | Hematochezia (HP:0002573) | 2.66311525 |
53 | Hypergammaglobulinemia (HP:0010702) | 2.63227114 |
54 | Hypochromic anemia (HP:0001931) | 2.62494971 |
55 | Abnormal platelet function (HP:0011869) | 2.62448105 |
56 | Impaired platelet aggregation (HP:0003540) | 2.62448105 |
57 | Viral hepatitis (HP:0006562) | 2.61203263 |
58 | Pustule (HP:0200039) | 2.60962157 |
59 | Autoimmune thrombocytopenia (HP:0001973) | 2.60434795 |
60 | B lymphocytopenia (HP:0010976) | 2.59581394 |
61 | Abnormality of B cell number (HP:0010975) | 2.59581394 |
62 | Orchitis (HP:0100796) | 2.57452491 |
63 | Abnormality of T cells (HP:0002843) | 2.55379314 |
64 | Eosinophilia (HP:0001880) | 2.53803861 |
65 | Abnormality of T cell physiology (HP:0011840) | 2.53677525 |
66 | Leukocytosis (HP:0001974) | 2.49646894 |
67 | Lymphopenia (HP:0001888) | 2.46532972 |
68 | Optic neuritis (HP:0100653) | 2.46388404 |
69 | Retrobulbar optic neuritis (HP:0100654) | 2.46388404 |
70 | Vacuolated lymphocytes (HP:0001922) | 2.45205543 |
71 | Gastrointestinal stroma tumor (HP:0100723) | 2.44003803 |
72 | Pulmonary embolism (HP:0002204) | 2.42924390 |
73 | Recurrent pneumonia (HP:0006532) | 2.42499288 |
74 | T lymphocytopenia (HP:0005403) | 2.42498145 |
75 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.40739250 |
76 | Nasal polyposis (HP:0100582) | 2.36708891 |
77 | Dysostosis multiplex (HP:0000943) | 2.34997421 |
78 | Granulocytopenia (HP:0001913) | 2.34494109 |
79 | Epistaxis (HP:0000421) | 2.33724592 |
80 | Chronic diarrhea (HP:0002028) | 2.32493206 |
81 | Periodontitis (HP:0000704) | 2.32135212 |
82 | Interstitial pulmonary disease (HP:0006530) | 2.30017178 |
83 | Skin rash (HP:0000988) | 2.29967670 |
84 | Abnormality of T cell number (HP:0011839) | 2.29727182 |
85 | Disinhibition (HP:0000734) | 2.28024071 |
86 | Gingivitis (HP:0000230) | 2.25443624 |
87 | Lymphoma (HP:0002665) | 2.25046310 |
88 | Microcytic anemia (HP:0001935) | 2.23041240 |
89 | Arterial thrombosis (HP:0004420) | 2.22753941 |
90 | Recurrent lower respiratory tract infections (HP:0002783) | 2.22316418 |
91 | Hypochromic microcytic anemia (HP:0004840) | 2.22312016 |
92 | Abnormality of eosinophils (HP:0001879) | 2.22179117 |
93 | Abnormality of the pleura (HP:0002103) | 2.20426002 |
94 | Abnormality of the nasal mucosa (HP:0000433) | 2.18258214 |
95 | Recurrent sinusitis (HP:0011108) | 2.17438179 |
96 | Sepsis (HP:0100806) | 2.15909927 |
97 | IgA deficiency (HP:0002720) | 2.15687153 |
98 | Encephalitis (HP:0002383) | 2.14336003 |
99 | Purpura (HP:0000979) | 2.13666291 |
100 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.13588970 |
101 | Pulmonary infiltrates (HP:0002113) | 2.12406346 |
102 | Combined immunodeficiency (HP:0005387) | 2.12297808 |
103 | Anorexia (HP:0002039) | 2.09370124 |
104 | Episodic fever (HP:0001954) | 2.08765191 |
105 | Abnormality of the prostate (HP:0008775) | 2.08040462 |
106 | Increased IgE level (HP:0003212) | 2.07052709 |
107 | Leukopenia (HP:0001882) | 2.06103519 |
108 | Chest pain (HP:0100749) | 2.05847935 |
109 | IgG deficiency (HP:0004315) | 2.05718135 |
110 | Gangrene (HP:0100758) | 2.05583369 |
111 | Stomatitis (HP:0010280) | 2.05547340 |
112 | Gingival bleeding (HP:0000225) | 2.05055180 |
113 | Cerebral aneurysm (HP:0004944) | 2.04555573 |
114 | Severe combined immunodeficiency (HP:0004430) | 2.04227768 |
115 | Restrictive lung disease (HP:0002091) | 2.03682372 |
116 | Skin ulcer (HP:0200042) | 2.03065598 |
117 | Acute hepatic failure (HP:0006554) | 2.02486591 |
118 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.02078626 |
119 | Slow saccadic eye movements (HP:0000514) | 1.98425767 |
120 | Thoracic kyphosis (HP:0002942) | 1.97270873 |
121 | Hypoplasia of the thymus (HP:0000778) | 1.97127078 |
122 | Increased serum ferritin (HP:0003281) | 1.96483270 |
123 | Abnormality of the peritoneum (HP:0002585) | 1.95743840 |
124 | Emphysema (HP:0002097) | 1.94279240 |
125 | Chronic sinusitis (HP:0011109) | 1.90418257 |
126 | Abnormal platelet volume (HP:0011876) | 1.89031931 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP4K1 | 4.50684606 |
2 | TGFBR2 | 3.21132323 |
3 | EEF2K | 2.91820252 |
4 | MAP3K10 | 2.77825658 |
5 | CSF1R | 2.76988284 |
6 | PRPF4B | 2.66695916 |
7 | TYK2 | 2.47052916 |
8 | STK10 | 2.40059537 |
9 | BLK | 2.26229509 |
10 | KIT | 2.17322941 |
11 | TXK | 2.02534111 |
12 | BTK | 1.98367852 |
13 | RIPK4 | 1.97846735 |
14 | ERN1 | 1.87199867 |
15 | ZAP70 | 1.86817877 |
16 | CDK12 | 1.85875655 |
17 | SYK | 1.82052399 |
18 | IRAK4 | 1.81550717 |
19 | GRK6 | 1.75366259 |
20 | CLK1 | 1.73389095 |
21 | TBK1 | 1.72423060 |
22 | MAP3K14 | 1.71944316 |
23 | JAK3 | 1.63770853 |
24 | HCK | 1.56351170 |
25 | IRAK3 | 1.56279364 |
26 | FES | 1.52799659 |
27 | PKN2 | 1.43783596 |
28 | IKBKB | 1.43304915 |
29 | SIK2 | 1.42397046 |
30 | TEC | 1.41780022 |
31 | PIM1 | 1.39838874 |
32 | ITK | 1.38130934 |
33 | JAK1 | 1.37756962 |
34 | CSK | 1.33241840 |
35 | IKBKE | 1.31466668 |
36 | MAP2K3 | 1.29338132 |
37 | LYN | 1.25655549 |
38 | NEK2 | 1.23974686 |
39 | TAOK3 | 1.20693243 |
40 | * LCK | 1.18364285 |
41 | FLT3 | 1.17412847 |
42 | STK4 | 1.16270219 |
43 | MATK | 1.15917992 |
44 | TSSK6 | 1.11925497 |
45 | SIK3 | 1.10281778 |
46 | LRRK2 | 1.05086512 |
47 | BMPR2 | 1.04866810 |
48 | PAK4 | 1.04357495 |
49 | CDK4 | 1.00953298 |
50 | MAP3K3 | 0.99113253 |
51 | CAMK1D | 0.98211234 |
52 | SMG1 | 0.96416884 |
53 | TAOK1 | 0.95863484 |
54 | EPHB1 | 0.93294571 |
55 | CHUK | 0.93190154 |
56 | RPS6KB2 | 0.92801480 |
57 | MAP3K1 | 0.92372947 |
58 | CDC7 | 0.89721860 |
59 | MAP3K13 | 0.88433033 |
60 | PRKCQ | 0.87109426 |
61 | CDK6 | 0.87067827 |
62 | MARK2 | 0.86874917 |
63 | RPS6KA4 | 0.85813262 |
64 | FGFR3 | 0.84026520 |
65 | JAK2 | 0.82780735 |
66 | MAPK15 | 0.81746500 |
67 | PIK3CG | 0.81575507 |
68 | SCYL2 | 0.78711229 |
69 | MARK3 | 0.76675413 |
70 | MAP3K8 | 0.75019731 |
71 | GRK7 | 0.72580597 |
72 | CDK19 | 0.72452696 |
73 | CAMK1G | 0.72021178 |
74 | MOS | 0.71219678 |
75 | VRK1 | 0.70879588 |
76 | PIM2 | 0.70662088 |
77 | TRPM7 | 0.69926707 |
78 | MAPKAPK3 | 0.69740601 |
79 | PRKD2 | 0.65758079 |
80 | BRD4 | 0.65292284 |
81 | CDC42BPA | 0.65204453 |
82 | ATR | 0.65043824 |
83 | TRIB3 | 0.63668115 |
84 | MAP3K7 | 0.63115272 |
85 | IRAK1 | 0.58959607 |
86 | YES1 | 0.58620074 |
87 | RPS6KA6 | 0.58300130 |
88 | MAPKAPK2 | 0.57045217 |
89 | MAPK12 | 0.56454732 |
90 | TAOK2 | 0.55790778 |
91 | PDPK1 | 0.55681199 |
92 | NME2 | 0.55183469 |
93 | MAPK4 | 0.54572955 |
94 | FYN | 0.53804012 |
95 | PTK6 | 0.52488997 |
96 | CDK7 | 0.51831402 |
97 | CDK9 | 0.51030454 |
98 | RPS6KC1 | 0.50693742 |
99 | RPS6KL1 | 0.50693742 |
100 | ALK | 0.50327458 |
101 | PDK1 | 0.49894928 |
102 | MAPK11 | 0.49466865 |
103 | MAP2K2 | 0.48412569 |
104 | MAPK7 | 0.47240743 |
105 | PASK | 0.46295483 |
106 | TNK2 | 0.46094464 |
107 | WEE1 | 0.45936709 |
108 | FGFR4 | 0.44989619 |
109 | NLK | 0.44760196 |
110 | HIPK2 | 0.44552175 |
111 | MAP3K6 | 0.43496279 |
112 | IRAK2 | 0.43375928 |
113 | NEK9 | 0.43084082 |
114 | TGFBR1 | 0.41552254 |
115 | ABL1 | 0.40847008 |
116 | CAMKK1 | 0.40566217 |
117 | TTK | 0.40223841 |
118 | KSR2 | 0.39479165 |
119 | STK11 | 0.36437465 |
120 | EGFR | 0.35673759 |
121 | TLK1 | 0.35094118 |
122 | RET | 0.34411458 |
123 | DYRK1B | 0.33770533 |
124 | GRK5 | 0.33609571 |
125 | KDR | 0.33544089 |
126 | MAP3K5 | 0.32666077 |
127 | TESK2 | 0.32235627 |
128 | FGR | 0.31338514 |
129 | SGK3 | 0.30884974 |
130 | MAP3K11 | 0.30718148 |
131 | MAP2K6 | 0.29323094 |
132 | MAPK3 | 0.28312095 |
133 | PRKCH | 0.28104658 |
134 | MELK | 0.27691700 |
135 | EIF2AK3 | 0.26000621 |
136 | RPS6KA2 | 0.25989655 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.18192756 |
2 | * B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.91475923 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.47434769 |
4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.43963344 |
5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.34251021 |
6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.22947456 |
7 | DNA replication_Homo sapiens_hsa03030 | 2.20698585 |
8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.19657436 |
9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.16769492 |
10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.12289150 |
11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.10019436 |
12 | Measles_Homo sapiens_hsa05162 | 1.92629476 |
13 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.89947318 |
14 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.85058533 |
15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.84044403 |
16 | Mismatch repair_Homo sapiens_hsa03430 | 1.81525236 |
17 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.80843138 |
18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.72104866 |
19 | Base excision repair_Homo sapiens_hsa03410 | 1.67559271 |
20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.65566303 |
21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52126252 |
22 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.51791817 |
23 | Tuberculosis_Homo sapiens_hsa05152 | 1.44525841 |
24 | Pertussis_Homo sapiens_hsa05133 | 1.44149638 |
25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.44025509 |
26 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.43901741 |
27 | Lysosome_Homo sapiens_hsa04142 | 1.43178332 |
28 | Legionellosis_Homo sapiens_hsa05134 | 1.40612838 |
29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39704315 |
30 | Apoptosis_Homo sapiens_hsa04210 | 1.37669023 |
31 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.36177631 |
32 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.35450169 |
33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.33527621 |
34 | Influenza A_Homo sapiens_hsa05164 | 1.31542931 |
35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.30013583 |
36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.29990573 |
37 | Hepatitis B_Homo sapiens_hsa05161 | 1.29412100 |
38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.29087920 |
39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.25208599 |
40 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.24799624 |
41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.24271371 |
42 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.21947011 |
43 | Homologous recombination_Homo sapiens_hsa03440 | 1.21232338 |
44 | Shigellosis_Homo sapiens_hsa05131 | 1.19813271 |
45 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.19137269 |
46 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.13759283 |
47 | Platelet activation_Homo sapiens_hsa04611 | 1.11455805 |
48 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.10838986 |
49 | Spliceosome_Homo sapiens_hsa03040 | 1.05291834 |
50 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.05236852 |
51 | Malaria_Homo sapiens_hsa05144 | 1.01721052 |
52 | Allograft rejection_Homo sapiens_hsa05330 | 0.95720136 |
53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.95186641 |
54 | Cell cycle_Homo sapiens_hsa04110 | 0.94071341 |
55 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.89875381 |
56 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.89343947 |
57 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.89271889 |
58 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.89124345 |
59 | HTLV-I infection_Homo sapiens_hsa05166 | 0.85988442 |
60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.85763299 |
61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.85460549 |
62 | Asthma_Homo sapiens_hsa05310 | 0.85338907 |
63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84596009 |
64 | Salmonella infection_Homo sapiens_hsa05132 | 0.82968817 |
65 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.82391671 |
66 | Colorectal cancer_Homo sapiens_hsa05210 | 0.82360576 |
67 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.81166104 |
68 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.80882613 |
69 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.80549365 |
70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.80049091 |
71 | Ribosome_Homo sapiens_hsa03010 | 0.79192611 |
72 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.76398725 |
73 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.76369582 |
74 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.76112457 |
75 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.75454505 |
76 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.73229001 |
77 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70424607 |
78 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.67510487 |
79 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.67448093 |
80 | RNA transport_Homo sapiens_hsa03013 | 0.65847032 |
81 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61109896 |
82 | Hepatitis C_Homo sapiens_hsa05160 | 0.60417150 |
83 | Endocytosis_Homo sapiens_hsa04144 | 0.59047231 |
84 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57338815 |
85 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56622769 |
86 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.55960790 |
87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53561876 |
88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.51568971 |
89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50192753 |
90 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49401397 |
91 | Phagosome_Homo sapiens_hsa04145 | 0.49313875 |
92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.46056255 |
93 | RNA degradation_Homo sapiens_hsa03018 | 0.46037650 |
94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45292482 |
95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44462776 |
96 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.43239833 |
97 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.42973781 |
98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42706828 |
99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42705478 |
100 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42581485 |
101 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42318902 |
102 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.41835691 |
103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.41555343 |
104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41397298 |
105 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40532863 |
106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39930151 |
107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.39055501 |
108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.38530845 |
109 | Insulin resistance_Homo sapiens_hsa04931 | 0.38205162 |
110 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38113463 |
111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.36604700 |
112 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36457734 |
113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35134155 |
114 | Lysine degradation_Homo sapiens_hsa00310 | 0.35076413 |
115 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34830856 |
116 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.34754241 |
117 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34033733 |
118 | * Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32999804 |
119 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.32395503 |
120 | Prostate cancer_Homo sapiens_hsa05215 | 0.27021163 |
121 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.26146400 |
122 | Amoebiasis_Homo sapiens_hsa05146 | 0.26021652 |
123 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.25302352 |
124 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.23064472 |
125 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.19555701 |
126 | Glioma_Homo sapiens_hsa05214 | 0.19110198 |
127 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.18858875 |